Experience, knowledge, and opinions about childhood genetic testing in Batten disease

Molecular Genetics and Metabolism

Volumn 111, Issue 2, 2014, Pages 197-202

  Adams, Heather R ^a   Rose, Katherine ^a   Augustine, Erika F ^a   Kwon, Jennifer M ^a   deBlieck, Elisabeth A ^a,b   Marshall, Frederick J ^a,b   Vierhile, Amy ^a   Mink, Jonathan W ^a   Nance, Martha A ^c  

^a UNIVERSITY OF ROCHESTER   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^c Struthers Parkinson's Center   (United States)

Author keywords

Child; Genetic testing; Neurologic disease disorder; Parental attitudes

Indexed keywords

ADULT; AGED; ARTICLE; DEGENERATIVE DISEASE; FAMILY; FEMALE; GENETIC COUNSELING; GENETIC SCREENING; HEALTH CARE SURVEY; HUMAN; INHERITANCE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NEURONAL CEROID LIPOFUSCINOSIS; PARENT; PREDICTION; PRIORITY JOURNAL; YOUNG ADULT;

AAP/ACMG; AMERICAN ACADEMY OF PEDIATRICS/AMERICAN COLLEGE OF MEDICAL GENETICS; BATTEN DISEASE SUPPORT AND RESEARCH ASSOCIATION; BDSRA; CHILD; DIRECT TO CONSUMER; DTC; FAMILIAL ADENOMATOUS POLYPOSIS; FAP; GENETIC INFORMATION NON DISCRIMINATION ACT; GENETIC TESTING; GENETIC TESTING IN CHILDREN; GINA; GTIC; HD; HUNTINGTON DISEASE; NCL; NEUROLOGIC DISEASE/DISORDER; NEURONAL CEROID LIPOFUSCINOSIS; PARENTAL ATTITUDES; RESEARCH SUBJECTS REVIEW BOARD; RSRB; UNIVERSITY OF ROCHESTER BATTEN CENTER; URBC;

ADULT; CHILD; EARLY DIAGNOSIS; FEMALE; GENETIC COUNSELING; GENETIC TESTING; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; NEURONAL CEROID-LIPOFUSCINOSES; PARENTS;

EID: 84893706725     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2013.10.017     Document Type: Article

References (33)

1. Santavuori P., Lauronen L., Kirveskari E., Åberg L., Sainio K., Autti T. Neuronal ceroid lipofuscinoses in childhood. Neurol. Sci. 2000, 21:S35-S41.
2. Mole S. MRC laboratory for molecular cell biology, NCL mutation and patient database (Access date, 23 Aug 2013). http://www.ucl.ac.uk/ncl/mutation.shtml.
3. Ross L., Saal H., David K., Anderson R. American Academy of Pediatrics, American College of Medical Genetics and Genomics, Technical report: ethical and policy issues in genetic testing and screening of children. Genet. Med. 2013, 15:234-245.
4. Committee on Bioethics, Committee on Genetics The American College of Medical Genetics, Genomics, Social, Ethical, and Legal Issues Committee, ethical and policy issues in genetic testing and screening of children. Pediatrics 2013, 131:620-622.
5. European Society of Human Genetics Genetic testing in asymptomatic minors: recommendations of the European Society of Human Genetics. Eur. J. Hum. Genet. 2009, 17:720-721.
6. Borry P., Evers-Kiebooms G., Cornel M., Clarke A., Dierick K. Genetic testing in asymptomatic minors. Background considerations towards ESHG Recommendations. Eur. J. Hum. Genet. 2009, 17. on behalf of the Public and Professional Policy Committee (PPPC) of the European Society of Human Genetics (ESHG).
7. Andrews L., Fullarton J., Holtzman N., Motulsky A. Committee on Assessing Genetic Risks - Division of Health Sciences Policy: Institute of Medicine, Implications for Health and Social Policy 1994, National Academy Press, Washington, DC.
8. Borry P., Stultiens L., Nys H., Cassiman J.J., Dierickx K. Presymptomatic and predictive genetic testing in minors: a systematic review of guidelines and position papers. Clin. Genet. 2006, 70:374-381.
9. Ross L.F. Predictive genetic testing for conditions that present in childhood. Kennedy Inst. Ethics J. 2002, 12:225-244.
10. Wertz D.C., Reilly P.R. Laboratory policies and practices for the genetic testing of children: a survey of the Helix network. Am. J. Hum. Genet. 1997, 61:1163-1168.
11. Duncan R.E., Savulescu J., Gillam L., Williamson R., Delatycki M.B. An international survey of predictive genetic testing in children for adult onset conditions. Genet. Med. 2005, 7:390-396.
12. Tarini B., Singer D., Clark S., Davis M. Parents' interest in predictive genetic testing for their children when a disease has no treatment. Pediatrics 2009, 124:e432-e438.
13. Codori A., Petersen G., Boyd P., Brandt J., Giardiello F. Genetic testing for cancer in children. Short-term psychological effect. Arch. Pediatr. Adolesc. Med. 1996, 150:1131-1138.
14. Codori A., Zawacki K., Peteresen G., Miglioretti D., Bacon J., Brensinger J., Booker S., Picarello K., Giardiello F. Genetic testing for hereditary colorectal cancer in children: long term psychological effects. Am. J. Med. Genet. 2003, 116A:117-128.
15. Michie S., Bobrow M., Marteau T. Predictive genetic testing in children and adults: a study of emotional impact. J. Med. Genet. 2001, 38:519-526.
16. Crystal R.G., Sondhi D., Hackett N.R., Kaminsky S.M., Worgall S., Stieg P., Souweidane M., Hosain S., Heier L., Ballon D., Dinner M., Wisniewski K., Kaplitt M., Greenwald B.M., Howell J.D., Strybing K., Dyke J., Voss H. Clinical protocol. Administration of a replication-deficient adeno-associated virus gene transfer vector expressing the human CLN2 cDNA to the brain of children with late infantile neuronal ceroid lipofuscinosis. Hum. Gene Ther. 2004, 15:1131-1154.
17. Selden N., Guillaume D., Steiner R., Huhn S. Cellular therapy for childhood neurodegenerative disease. Part II: clinical trial design and implementation. Neurosurg. Focus. 2008, 24:E23.
18. Worgall S., Sondhi D., Hackett N., Kosofsky B., Kekatpure M., Neyzi N., Dyke J., Ballon D., Heier L., Greenwald P., Christos M., Mazumdar M., Souweidane M., Kaplitt M., Crystal R. Treatment of late infantile neuronal ceroid lipofuscinosis by CNS administration of a serotype 2 adeno-associated virus expressing CLN2 cDNA. Hum. Gene Ther. 2008, 19:463-474.
19. Geller G., Tambor E., Bernhardt B., Fraser G., Wissow L. Informed consent for enrolling minors in genetic susceptibility research: a qualitative study of at-risk children's and parents' views about children's role in decision-making. J. Adolesc. Health 2003, 32:260-271.
20. Geller G., Tambor E., Bernhardt B., Wissow L., Fraser G. Mothers and daughters from breast cancer families: a qualitative study of their perspective of the risks and benefits associated with minors' participation in genetic susceptibility research. J. Am. Med. Womens Assoc. 2000, 55:280-284.
21. Gustafsson Stolt U., Liss P., Ludvigsson J., Abis Study Group Parents want to know if their child is at high risk of getting diabetes. Ann. N.Y. Acad. Sci. 2003, 1005:395-399.
22. Helgesson G., Swartling U. Views on data use, confidentiality, and consent in a predictive screening involving children. J. Med. Ethics 2008, 34:206-209.
23. Twomey J.G., Bove C., Cassidy D. Presymptomatic genetic testing in children for neurofibromatosis 2. J. Pediatr. Nurs. 2008, 23:183-194.
24. Borry P., Howard H., Senecal K., Avard D. Health-related direct-to-consumer genetic testing: a review of companies' policies with regard to genetic testing in minors. Fam. Cancer 2010, 9:51-59.
25. Howard H., Avard D., Borry P. Are the kids really all right? Direct-to-consumer genetic testing in children: are company policies clashing with professional norms?. Eur. J. Hum. Genet. 2011, 19:1122-1126.
26. Dvoskin R., Kaufman D. Tables of Direct-to-Consumer Genetic Testing Companies and Conditions Tested - August 2011 2011, Genetics and Public Policy Center, (http://www.dnapolicy.org/pub.reports.php?action=detail&report_id=28. Access date, 23 Aug 2013).
27. 23andMe Inc. Neuronal ceroid lipofuscinosis (PPT1-related) (access date 18 Oct 2013). https://www.23andme.com/health/ppt1-related-ncl/.
28. 23andMe Inc. Neuronal ceroid lipofuscinosis (CLN-5 related) (access date 18 Oct 2013). https://www.23andme.com/health/cln5-related-ncl/.
29. Illumina Illumina home page, illumina (Access date, 18 Oct 2013). http://www.illumina.com/.
30. Michie S., McDonald V., Bobrow M., McKeown C., Marteau T. Parents' responses to predictive genetic testing in their children: report of a single case study. J. Med. Genet. 1996, 33:313-318.
31. Järvinen O., Lehesjoki A.-L., Lindlöf M., Uutela A., Kääriäinen H. Carrier testing of children for two X-linked diseases: a retrospective study of comprehension of test results and social and psychological significance of the testing. Pediatrics 2000, 106:1460-1465.
32. Braithwaite D., Emery J., Walter F., Prevost A., Sutton S. Psychological impact of genetic counseling for familial cancer: a systematic review and meta-analysis. J. Natl. Cancer Inst. 2004, 96:122-133.
33. Genetic Information Non-discrimination Act of 2008, Pub. L. 110-233. 122 Stat. 881 May 21 2008.